Skip to Main Content

Paper Details

Efficacy of the novel tubulin polymerization inhibitor PTC-028 for myelodysplastic syndrome.
Cancer Sci
5
2020
HCl, MCL-1, MDS, MDS cell line, MDS cell lines, MDS cells, MDS samples, MDS-L, PTC-028, PTC028, PTC596, acute myeloid leukemia, acute myeloid leukemia cells, anticancer, azacitidine, decitabine, mice, mouse, myelodysplastic syndrome, p53, solid tumors, tubulin
Author NameAffiliation
Atsushi MiyawakiCenter for Brain Science
Marla Weetall
Atsushi IwamaCenter for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo
  • 1 - 3

Datasets

Release 1.2